Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Cerivastatin's Setback to Favor Sankyo's Mevalotin
September 10, 2001
- MEDICAL DEVICE NEWS IN BRIEF
September 10, 2001
- REGULATORY NEWS IN BRIEF -2-
September 10, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
September 10, 2001
- REGULATORY NEWS IN BRIEF -1-
September 10, 2001
- Sanyo, NEC Tie Up Regarding Medical Information Systems
September 10, 2001
- Mr Hashimoto Stresses Establishing Durable Social Security System
September 10, 2001
- WORLD NEWS IN BRIEF
September 10, 2001
- Healthcare Industry Can Be Driving Power of Economy: METI Minister
September 10, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
September 10, 2001
- METI Demands \1,015.1 Bil., Up 9.09%
September 10, 2001
- Clinical Study to Collect Data on Ethnic Differences Completed
September 10, 2001
- Monkasho Demands \91,023 Mil. to Promote Life Science
September 10, 2001
- Fosamac Reduces Multiple New Fracture Risk by up to 70% in Osteoporosis: Banyu Seminar
September 10, 2001
- Korosho Demands Budget of \18,745.5 Bil. for FY2002, Up 3.63%
September 10, 2001
- Combination of Thrombolytic, Cerebral Protective Agents Recommended for CI: MTP Seminar
September 10, 2001
- Korosho to Propose Healthcare System Reform at End of Sept.
September 10, 2001
- Jovi to Tie Up with CGC Japan
September 3, 2001
- 10 New Ingredients Added to NHI Price List
September 3, 2001
- Seijo to Tie Up with Fuji Yakuhin, Mine Yakuhin
September 3, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…